Rod D. Martin, Director at GALECTIN THERAPEUTICS INC (GALT), bought 5,000 shares at $2.44 ($12K) on 2012-05-25, disclosed to the SEC on 2012-05-25.
Open-market purchase of $12k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |